GPT and fatty liver disease: Unfortunately mipomersen received multiple black-box warnings from the FDA due to hepatotoxicity risk, with common adverse reactions including hepatic steatosis and elevations in serum transaminases like alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (U.S. Food and Drug Administration, 2019).